1. Novel pendrin inhibitor attenuates airway hyperresponsiveness and mucin
expression in experimental murine asthma. Jinhong Park, Hyun Jae Lee, Doona
Song, Mia Gi, Sungwoo Jo, Dong-kyu Jeon, Yohan Seo, Bomin Kim, Ho Lee, Wan
Namkung, Gyoonhee Han, Jae Young Choi, Journal of Allergy and Clinical
Immunology, 2019, 144, 1425.
2. Therapeutic effects of the novel Leucyl-tRNA synthetase inhibitor BC-LI-0186 in
non-small cell lung cancer. un Young Kim, Jin Gu Lee, Jung Mo Lee, Arum Kim,
Hee Chan Yoo, Kibum Kim, Minji Lee, Chulho Lee, Gyoonhee Han, Jung Min Han,
Yoon Soo Chang, Therapeutic Advances in Medical Oncology, 2019, 11,
1758835919846798.
3. Nontranslational function of leucyl-tRNA synthetase regulates myogenic
differentiation and skeletal muscle regeneration. Kook Son, Jae-Sung You, Mee-Sup
Yoon, Chong Dai, Jong Hyun Kim, Nidhi Khanna, Aditi Banerjee, Susan A
Martinis, Gyoonhee Han, Jung Min Han, Sunghoon Kim, Jie Chen, The Journal of
Clinical Investigation, 2019, 129. 2088.
4. CXXC5 mediates growth plate senescence and is a target for enhancement of
longitudinal bone growth. Sehee Choi, Hyun-Yi Kim, Pu-Hyeon Cha, Seol Hwa Seo,
Chulho Lee, Yejoo Choi, Wookjin Shin, Yunseok Heo, Gyoonhee Han, Weontae
Lee, Kang-Yell Choi, Life Science Alliance, 2019, 2, e201800254
等论文 86篇
 
1. Non-calcemic, antiproliferative, transcriptionally active sulfer-comtaining analogs of
1a, 25-dihydroxy vitamin D3. US006380408 (B1), April, 30, 2002
2. Imidazopyrimidine Deriatives and Triazolopyrimidine Derivatives as Syk Kinase
Inhibitors. US06911443, June 28, 2005.
3. Novel 2-oxo-heterocyclic compounds and the pharmaceutical compositions
comprising the same. ZL 2004 8 0013231.0(Chinese), Sept. 02, 2009.
4. Preparation of benzoxazoles and related compounds for inhibiting 5-lipoxygenase.
US 20070066577, March 22, 2007
 
专利4项